MGNX - Macrogenics Inc
IEX Last Trade
3.52
0.050 1.420%
Share volume: 1,276,805
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.47
0.05
1.44%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-03 | 2023-03-15 | 2023-05-09 | 2023-08-09 | 2023-11-06 | 2024-03-07 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 218.043 M | 195.347 M | 280.468 M | 343.498 M | 305.653 M | 339.972 M | 298.418 M | 248.285 M | |
| Current Assets | 167.633 M | 147.812 M | 222.180 M | 288.943 M | 254.675 M | 291.319 M | 251.339 M | 202.575 M | |
| Inventories | 2.949 M | 1.086 M | 1.451 M | 1.409 M | 1.443 M | 1.066 M | 1.221 M | 1.248 M | |
| Other Current Assets | 12.559 M | 9.273 M | 10.161 M | 9.718 M | 6.475 M | 8.510 M | 9.946 M | 9.871 M | |
| Short Term Investments | 12.559 M | 9.273 M | 10.161 M | 9.718 M | 6.475 M | 8.510 M | 9.946 M | 9.871 M | |
| Total Receivables | 18.385 M | 13.837 M | 56.222 M | 36.160 M | 6.410 M | 25.311 M | 10.367 M | 7.219 M | |
| Current Cash | 133.740 M | 123.616 M | 154.346 M | 241.656 M | 240.347 M | 256.432 M | 229.805 M | 184.237 M | |
| Total Non-current Assets | 50.410 M | 47.535 M | 58.288 M | 54.555 M | 50.978 M | 48.653 M | 47.079 M | 45.710 M | |
| Property Plant Equipment | 34.022 M | 31.993 M | 29.575 M | 26.783 M | 24.091 M | 22.634 M | 21.847 M | 21.296 M | |
| Other Assets | 16.388 M | 15.542 M | 28.713 M | 27.772 M | 26.887 M | 26.019 M | 25.232 M | 24.414 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 218.043 M | 195.347 M | 280.468 M | 343.498 M | 305.653 M | 339.972 M | 298.418 M | 248.285 M | |
| Total liabilities | 75.562 M | 72.389 M | 138.455 M | 234.230 M | 134.109 M | 145.992 M | 145.805 M | 142.131 M | |
| Total current liabilities | 50.877 M | 50.046 M | 48.611 M | 45.614 M | 45.155 M | 51.291 M | 56.108 M | 55.764 M | |
| Accounts Payable | 2.609 M | 4.619 M | 4.899 M | 3.759 M | 3.795 M | 3.303 M | 6.443 M | 10.694 M | |
| Other liabilities | 6.421 M | 5.342 M | 59.738 M | 58.264 M | 58.796 M | 64.518 M | 59.501 M | 56.440 M | |
| Current long term debt | 4.940 M | 5.021 M | 4.726 M | 4.418 M | 4.161 M | 3.926 M | 3.775 M | 4.085 M | |
| Long term debt | 18.264 M | 17.001 M | 30.106 M | 130.352 M | 30.158 M | 30.183 M | 30.196 M | 29.927 M | |
| Other liabilities | 6.421 M | 5.342 M | 59.738 M | 58.264 M | 58.796 M | 64.518 M | 59.501 M | 56.440 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 142.481 M | 122.958 M | 142.013 M | 109.268 M | 171.544 M | 193.980 M | 152.613 M | 106.154 M | |
| Common stock | 61.385 M | 61.460 M | 61.564 M | 61.810 M | 61.880 M | 61.981 M | 62.046 M | 62.291 M | |
| Retained earnings | -1.082 B | -1.106 B | -1.094 B | -1.132 B | -1.074 B | -1.057 B | -1.103 B | -1.155 B |